Package Leaflet: Information for the Patient
Tentin 5mg tablets
Tentin 10mg tablets
Tentin 20 mg tablets
dexanfetamine, sulfate
Read this package leaflet carefully before your child starts taking this medicine, as it contains important information for you.
Contents of the Package Leaflet
What is Tentin
Tentin tablets contain the active substance dexanfetamine, sulfate.
Tentin is a psycho-stimulant. It improves activity in parts of the brain. This medicine may help improve attention and concentration and reduce impulsive behavior.
What is it used for
Tentin is used to treat attention deficit hyperactivity disorder (ADHD).
Treatment with this medicine should only be started and used under the supervision of a specialist in child and adolescent behavioral disorders.
You should consult a doctor if your child does not improve or worsens after one month. The doctor may decide that a different treatment is necessary.
Do not use Tentin if your child:
Do not use this medicine if your child has any of the above conditions. If you are unsure, consult your doctor or pharmacist before using dexanfetamine. The reason is that this medicine may worsen the mentioned problems.
Warnings and precautions
Consult your doctor or pharmacist before starting to take dexanfetamine if your child:
Tell your doctor or pharmacist if your child is in any of these circumstances before starting treatment. The reason is that this medicine may worsen the mentioned problems. Your doctor will want to monitor how the medicine affects your child.
Checks that your doctor will perform before using Tentin
These checks are to decide if this medicine is suitable for your child. Your doctor will discuss with you:
The doctor will assess if your child is at risk of mood swings (from manic to depressed, also known as bipolar disorder). The doctor will check your child's mental health history and if any family member has a history of suicide, bipolar disorder, or depression.
It is essential that you provide all the information you can. This will help the doctor decide if this medicine is suitable for your child. Your doctor may decide that other medical tests are necessary before starting this medicine.
Effect on weight/growth
This medicine may cause weight loss in some children and adolescents.
Surgical interventions
Tell your doctor if your child is going to have an operation. This medicine should not be taken on the day of surgery if a certain type of anesthesia is used. This is because there is a possibility of a sudden increase in blood pressure during surgery.
Drug tests
This medicine may give a positive result in a drug test.
Pharmacological interactions in analytical tests
This medicine may interfere with laboratory test results.
Children and adolescents
This medicine should not be used to treat ADHD in children under 6 years old or in adults. It is not known if it is safe or effective for these people.
Other medicines and Tentin
Tell your doctor or pharmacist if your child is taking, has recently taken, or might take any other medicine, including those without a prescription.
Monoamine oxidase inhibitors
Do not use this medicine if your child is taking a medicine called "monoamine oxidase inhibitor" (MAOI) used for depression or if they have taken an MAOI in the last 14 days. Taking an MAOI with dexanfetamine may cause a sudden increase in blood pressure.
If your child is taking other medicines, this medicine may affect their efficacy or cause side effects. If your child is taking any of the following medicines, consult your doctor or pharmacist before using this medicine:
It is essential that you consult your pharmacist when buying any of these medicines.
If you are unsure if any of the medicines your child is taking are included in the above list, consult your doctor or pharmacist before your child takes this medicine.
Using Tentin with alcohol
Do not consume alcohol while taking this medicine. Remember that some foods and medicines contain alcohol.
Pregnancy and breastfeeding
Available data on the use of this medicine during the first three months of pregnancy do not indicate an increased risk of congenital malformations in the child, but may increase the risk of preeclampsia (a disease that usually appears after 20 weeks of pregnancy and is characterized by high blood pressure and protein in the urine) and premature birth. Newborns exposed to amphetamines during pregnancy may experience withdrawal symptoms (behavioral changes that include excessive crying, unstable or irritable mood, hyperexcitability, and pronounced exhaustion).
If your daughter is pregnant or breastfeeding, thinks she may be pregnant, or plans to become pregnant, consult your doctor or pharmacist before using this medicine.
Driving and using machines
Your child may feel dizzy, have concentration problems, or blurred vision when taking this medicine. If so, it may be dangerous to do things like driving, using machines, riding a bike, or climbing trees.
Tentincontains isomalt (E953)
If your doctor has told you that your child has an intolerance to certain sugars, consult with them before taking this medicine.
How much to take
Follow exactly the administration instructions of this medicine indicated by your doctor. In case of doubt, ask your doctor or pharmacist.
The recommended dose is between 5 mg and 20 mg.
How to take it
The medicine is administered orally.
Your child should take the tablets of this medicine with a glass of water, preferably with meals or immediately after them. The Tentin tablets should be taken at the same time with respect to meals. In general, the last dose should not be administered too late after the meal to avoid sleep problems.
The tablets have a score line and can be divided if necessary. The score line is only for breaking the tablet if it is difficult to swallow whole. To break it, place the tablet on a hard surface with the smooth and scored face down and then press gently with your index finger in the center of the top face. The tablet will break into four parts.
If your child does not feel better, tell your doctor. The doctor may decide that a different treatment is necessary.
Long-term treatment
Your doctor will decide the duration of treatment. If your child takes this medicine for more than a year, the doctor may interrupt treatment for a short period, e.g., during school holidays. This will indicate if the medicine is still necessary.
Incorrect use of Tentin
If this medicine is not used correctly, it may cause abnormal behavior. It may also mean that your child starts to depend on the medicine. Tell your doctor if your child has ever had excessive use or dependence on alcohol, prescription medications, or drugs.
This medicine is only for your child. Do not give it to others, even if the symptoms seem similar.
If your child takes more Tentin than they should
In case of overdose or accidental ingestion, consult a doctor, pharmacist, or call the Toxicology Information Service, phone 915620420, indicating the medicine and the amount taken.
Show the doctor the package or this package leaflet. Overdose of these tablets can have very serious consequences.
Signs of overdose may include: excitement, hallucinations, convulsions leading to coma, irregular and rapid heartbeat, and reduced breathing.
If your child forgets to take Tentin
Do not take a double dose to make up for forgotten doses. If your child forgets a dose, wait until it is time for the next one.
If your child stops taking Tentin
If your child stops taking this medicine abruptly, they may experience extreme fatigue, depression, mood disorders, psychomotor excitement, sleep disturbances, increased appetite, or involuntary movements. Your doctor may want to gradually reduce the amount of medicine taken each day before stopping it completely. Consult your doctor before stopping treatment with this medicine.
If you have any other questions about the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause adverse effects, although not all people suffer from them. Your doctor will discuss these adverse effects with you.
Stop administering Tentin and consult a doctor or go to an emergency center immediately if your child experiences the following symptoms:
Other Adverse Effects
Very Common: may affect more than 1 in 10 people
Common: may affect up to 1 in 10 people
These effects usually occur at the start of treatment and can be alleviated by taking the medicine with meals.
Uncommon: may affect up to 1 in 1,000 people
Very Rare: may affect up to 1 in 10,000 people
Frequency Not Known: cannot be estimated from available data
Reporting Adverse Effects
If you experience any adverse effects, consult your doctor or pharmacist, even if they are not listed in this leaflet. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: https://www.notificaram.es. By reporting adverse effects, you can contribute to providing more information on the safety of this medicine.
Keep this medicine out of sight and reach of children.
Do not use this medicine after the expiration date shown on the blister pack and carton after "EXP". The expiration date is the last day of the month indicated.
Do not store above 25 °C.
Keep in the original packaging to protect from moisture.
Medicines should not be disposed of via wastewater or household waste. Deposit the packaging and unused medicines at the pharmacy's SIGRE point. If in doubt, ask your pharmacist how to dispose of the packaging and medicines you no longer need. This will help protect the environment.
What Tentin contains:
Tentin 5 mg:
One tablet contains 5 mg of dexamfetamine sulfate
Tentin 10 mg:
One tablet contains 10 mg of dexamfetamine sulfate
Tentin 20 mg:
One tablet contains 20 mg of dexamfetamine sulfate
isomalt (E953), see section 2
magnesium stearate
crospovidone in 5 mg tablets
yellow iron oxide (E 172) in 10 mg tablets
red iron oxide (E 172) in 20 mg tablets
Appearance and Package Contents:
Tentin 5 mg tablets
White, round, cloverleaf-shaped tablets with a cross-shaped notch on the top surface and a cross-shaped notch and an "S" embossed in relief on each quarter of the bottom surface.
The notch is only for fracturing and facilitating swallowing, but not for dividing into equal doses.
Package sizes: 20, 28, 30, 50, 98, or 100 tablets
Boxes with tablets packaged in PVC/PE/PVdC and aluminum foil blisters
Tentin 10 mg tablets
Yellow, round, cloverleaf-shaped tablets with a cross-shaped notch on the top surface and a cross-shaped notch and an "M" embossed in relief on each quarter of the bottom surface.
The notch is only for fracturing and facilitating swallowing, but not for dividing into equal doses.
Package sizes: 20, 28, 30, 48, or 50 tablets
Boxes with tablets packaged in PVC/PVdC and aluminum foil blisters
Tentin 20 mg tablets
Reddish, round, cloverleaf-shaped tablets with a cross-shaped notch on the top surface and a cross-shaped notch and an "L" embossed in relief on each quarter of the bottom surface.
The notch is only for fracturing and facilitating swallowing, but not for dividing into equal doses.
Package sizes: 20, 28, or 30 tablets
Boxes with tablets packaged in PVC/PVdC and aluminum foil blisters
Not all package sizes may be marketed.
Marketing Authorization Holder and Manufacturer
MEDICE Arzneimittel Pütter GmbH & Co. KG
Kuhloweg 37
58638 Iserlohn
Germany
This medicine is authorized in the Member States of the European Economic Area and in the United Kingdom (Northern Ireland) under the following names:
Austria: Philla 5 mg/10 mg/20 mg Tablet
Belgium: Attentin 5 mg/10 mg/20 mg Tablets
Estonia: Tentin 5 mg/10 mg/20 mg Tablet
Spain: Tentin 5 mg/10 mg/20 mg tablets
France: Tentin 5 mg/10 mg/20 mg comprimé
Italy: Amfexa 5 mg/10 mg/20 mg compressa
Poland: Tentin 5 mg/10 mg/20 mg Tabletka
Portugal: Tentin 5 mg/10 mg/20 mg comprimido
Denmark: Attentin 5 mg/10 mg/20 mg
Finland: Attentin 5 mg/10 mg/20 mg
Iceland: Attentin 5 mg/10 mg/20 mg
Luxembourg: Attentin 5 mg/10 mg/20 mg
Norway: Attentin 5 mg/10 mg/20 mg
Sweden: Attentin 5 mg/10 mg/20 mg
United Kingdom (Northern Ireland): Amfexa 5 mg/10 mg/20 mg tablet
This leaflet is also available in formats suitable for the blind and visually impaired.
Date of last revision of this leaflet:February 2025
Detailed information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) (http://www.aemps.gob.es/).